13 in the journal JAMA Network Open. By comparison, Saxenda (liraglutide) prompted similar weightloss in only 29% of those being treated for obesity and 12% being treated for type 2 diabetes.
Weight-loss injections have revolutionized obesity treatment in adults, and now, their effectiveness has been proven in children. A new study revealed that the injection "Saxenda" led to ...